# Peptide Testimonials — Research Peptide Fundamentals research peptides > Four research peptides — GHK-Cu, KPV, semaglutide, tirzepatide — with what the published studies show set directly next to what people report in research-use communities, labeled anecdotal. No products, no customer reviews, no medical advice. A straight-talking primer on four widely discussed research peptides — GHK-Cu, KPV, semaglutide, and tirzepatide — separating what has actually been measured in a lab or a trial from what is merely reported in research-use communities. ## The short version Peptide Testimonials is not a store, and nothing on this site is a customer review. "Testimonials" in the name points at something narrower: what people in research-use communities say happened when they used a compound, set directly next to what a controlled study actually measured. Those are two different kinds of information, and treating them as interchangeable is how a lot of peptide marketing goes wrong. A **research peptide** is a short chain of amino acids — the same building blocks every protein in the body is made from — that scientists study for a specific biological effect. Some peptides, like semaglutide, have gone all the way through clinical trials and become approved medicines taken by millions. Others, like KPV, have never been tested in a single human trial; everything known about them comes from mice and lab dishes. This site covers four peptides that sit at very different points on that spectrum — GHK-Cu, KPV, semaglutide, and tirzepatide — and says plainly which is which. Nothing here recommends a dose, a use, or a course of action for any person. ## The gap this site exists to close Every peptide covered here has two separate records. One is the **published record**: peer-reviewed trials, mechanistic studies, and safety reviews — things that were measured, reported with real numbers, and can be checked against a citation. The other is the **community record**: what people in research and patient forums say they noticed, good and bad, entirely unverified and never a substitute for the first kind. The two records rarely line up cleanly. Semaglutide has the deepest published record of anything on this desk — tens of thousands of trial participants across half a dozen major trials — and also one of the largest bodies of user-reported experience anywhere in peptide research, simply because it is an approved drug taken by millions of people. KPV sits at the opposite extreme: no human trials exist at all, so there is effectively no honest community record to report either, whatever chatter turns up in a search. GHK-Cu falls in between — decent small human skin trials, next to online claims that run considerably ahead of what those trials actually showed. Every compound page on this site draws that line explicitly: what the studies show, in one section, and what people report, in another, clearly labeled **anecdotal, not clinical evidence**. ## What are research peptides? The four compounds here cover three genuinely different categories, and lumping them together is part of why the marketing around peptides gets muddled. GHK-Cu is a copper-binding tripeptide, originally identified in human plasma and used almost entirely as a topical cosmetic ingredient. KPV is a melanocortin-derived anti-inflammatory tripeptide, studied only in cell culture and animal models of gut inflammation, with no approved use anywhere. Semaglutide and tirzepatide are both GLP-1-pathway receptor agonists — synthetic peptides engineered to resist rapid breakdown so they can be dosed weekly — and both are FDA-approved prescription medicines with large randomized trial programs behind them. Regulatory status varies just as sharply. Topical Copper Tripeptide-1 (GHK-Cu) is a legal cosmetic ingredient; injecting or otherwise taking it systemically is unapproved and unstudied in humans. KPV is sold only as a laboratory research chemical, with no dietary-supplement or drug status in any major jurisdiction. Semaglutide and tirzepatide are approved prescription medicines available only through a licensed provider. This site describes what has been studied and reported for each — it does not sell, source, or recommend any of them. ## How this site is organized Each compound gets its own page with the same arc: what it is, how it works, what the controlled research actually shows (cited by number), and what people report using it, clearly separated and labeled. The [compare page](/compare) lines up all four side by side on the evidence-versus-anecdote question directly, and every citation used anywhere on this site is collected once on the [references page](/references). Read [GHK-Cu](/ghk-cu), [KPV](/kpv), [semaglutide](/semaglutide), or [tirzepatide](/tirzepatide) individually, or start with the comparison to see the full spread at a glance. --- This is a research digest that keeps what a study measured separate from what a forum member reported — it is not a clinic, not a supplier, and not medical advice.